In vivo biodistribution and pharmacokinetics of 18F-labeled human C-peptide: evaluation in monkeys using positron emission tomography
- 1 August 2002
- journal article
- Published by Elsevier in Life Sciences
- Vol. 71 (12) , 1361-1370
- https://doi.org/10.1016/s0024-3205(02)01859-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor ratDiabetologia, 2001
- Beneficial effects of C‐peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitusDiabetic Medicine, 2000
- Specific binding of proinsulin C-peptide to human cell membranesProceedings of the National Academy of Sciences, 1999
- Effects of C-peptide on renal function at the early stage of experimental diabetesKidney International, 1998
- Prevention of Vascular and Neural Dysfunction in Diabetic Rats by C-PeptideScience, 1997
- C-peptide improves autonomic nerve function in IDDM patientsDiabetologia, 1996
- C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide YDiabetologia, 1996
- Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1Journal of Clinical Endocrinology & Metabolism, 1993
- Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic manMetabolism, 1987
- Metabolism of Proinsulin, Insulin, and C-Peptide in the RatJournal of Clinical Investigation, 1973